# Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II)

> **NCT04321278** · PHASE3 · COMPLETED · sponsor: **Hospital Israelita Albert Einstein** · enrollment: 440 (actual)

## Conditions studied

- Coronavirus Infections
- Pneumonia, Viral

## Interventions

- **DRUG:** Hydroxychloroquine + azithromycin
- **DRUG:** Hydroxychloroquine

## Key facts

- **NCT ID:** NCT04321278
- **Lead sponsor:** Hospital Israelita Albert Einstein
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-28
- **Primary completion:** 2020-06-14
- **Final completion:** 2020-06-14
- **Target enrollment:** 440 (ACTUAL)
- **Last updated:** 2021-01-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04321278

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04321278, "Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II)". Retrieved via AI Analytics 2026-09-13 from https://api.ai-analytics.org/clinical/NCT04321278. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*